If having strong or moderate inhibitors of CYP3A4, the dose of LEVITRA needs to be modified as follows: à é . : ------------------------------------------------------------------ Doctors need to recommend clients to stop taking all PDE5 inhibitors, including LEVITRA, and find prompt health care consideration during the event of sudden lessen or loss https://johnathanbjury.blog2learn.com/83445776/rumored-buzz-on-hbr-case-study-solution